简短干预对重症监护病房有害酒精使用患者的效果:一项随机对照试验
该随机对照试验纳入234例急诊入院的成年ICU患者(AUDIT-C评分女性>5、男性>6),比较简短干预(BI)与常规治疗(TAU)对酒精摄入的影响。主要终点为随机化后6个月和12个月自我报告的过去一周酒精消耗量。6个月时BI组中位摄入6.5 g(IQR 0-141)vs TAU组0 g(0-72),p=0.544;12个月时BI组24 g(0-146)vs TAU组0 g(0-96),p=0.157。AUDIT-C评分变化及死亡率均无组间显著差异。研究因疫情期间招募缓慢而提前终止,作者认为研究把握度不足,无法拒绝或证实单次BI早期减少酒精摄入的假设。
要点
- 纳入标准:急诊入院的成年ICU患者,AUDIT-C评分女性>5分、男性>6分。
- 主要终点6个月酒精摄入:BI组中位6.5 g(IQR 0-141)vs TAU组0 g(0-72),p=0.544。
- 主要终点12个月酒精摄入:BI组中位24 g(IQR 0-146)vs TAU组0 g(0-96),p=0.157。
- AUDIT-C评分变化:6个月BI组-1(-4至0)vs TAU组2(-6至0),p=0.144;12个月BI组-3(-5至-1)vs TAU组-4(-7至-1),p=0.187。
- 研究因招募缓慢提前终止,作者认为把握度不足,不能拒绝或证实单次BI早期减少酒精摄入的假设。
适用人群与场景
- 芬兰三家大学医院急诊入院的成年ICU患者,AUDIT-C评分女性>5分、男性>6分。
诊断标准与关键阈值
- 使用酒精使用障碍识别测试-消耗量(AUDIT-C)评分评估酒精使用史,纳入标准为女性AUDIT-C评分>5分、男性>6分。
处置流程与药物剂量
- 简短干预(BI)在ICU出院时或出院后不久在病房内实施。
- 对照组接受常规治疗(TAU)。
研究设计与关键结果
- 随机对照试验,纳入234例患者,BI组117例、TAU组117例,来自芬兰三家大学医院。
- 主要终点6个月自我报告过去一周酒精摄入量:BI组中位6.5 g(IQR 0-141)vs TAU组0 g(0-72),p=0.544。
- 主要终点12个月酒精摄入量:BI组中位24 g(IQR 0-146)vs TAU组0 g(0-96),p=0.157。
- AUDIT-C评分从基线至6个月中位变化:BI组-1(-4至0)vs TAU组2(-6至0),p=0.144。
- AUDIT-C评分从基线至12个月中位变化:BI组-3(-5至-1)vs TAU组-4(-7至-1),p=0.187。
- 6个月戒酒率:BI组4%(n=5)vs TAU组11%(n=13);12个月戒酒率:BI组10%(n=12)vs TAU组15%(n=17)。
- 死亡率无组间差异。
- 研究因疫情期间招募缓慢而提前终止。
证据类型、等级与局限
- 证据类型:随机对照试验。
- 局限性:研究因疫情期间招募缓慢而提前终止;作者指出研究把握度不足,无法拒绝或证实单次BI早期减少酒精摄入的假设。
对床旁实践的改变
- 作者认为,由于研究把握度不足,不能拒绝或证实单次简短干预在危重病后早期减少酒精摄入的效果优于常规治疗;但两组均有相当数量患者减少了酒精消耗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Screening for hazardous alcohol use and performing brief interventions (BIs) are recommended to reduce alcohol-related negative health consequences. We aimed to compare the effectiveness (defined as an at least 10% absolute difference) of BI with usual care in reducing alcohol intake in intensive care unit survivors with history of hazardous alcohol use.
METHODS: We used Alcohol Use Disorder Identification Test-Consumption (AUDIT-C) score to assess history of alcohol use.
PATIENTS: Emergency admitted adult ICU patients in three Finnish university hospitals, with an AUDIT-C score > 5 (women), or > 6 (men). We randomized consenting eligible patients to receive a BI or treatment as usual (TAU).
INTERVENTION: BI was delivered by the time of ICU discharge or shortly thereafter in the hospital ward.
CONTROLS: Control patients received TAU.
OUTCOME: The primary outcome was self-reported alcohol consumption during the preceding week 6 and 12 months after randomization. Secondary outcomes were the change in AUDIT-C scores from baseline to 6 and 12 months, health-related quality of life, and mortality. The trial was terminated early due to slow recruitment during the pandemic.
RESULTS: We randomized 234 patients to receive BI (N = 117) or TAU (N = 117). At 6 months, the median alcohol intake in the BI and TAU groups were 6.5 g (interquartile range [IQR] 0-141) and 0 g (0-72), respectively (p = 0.544). At 12 months, it was 24 g (0-146) and 0 g (0-96) in the BI and TAU groups, respectively (p = 0.157). Median change in AUDIT-C from baseline to 6 months was - 1 (- 4 to 0) and 2 (- 6 to 0), (p = 0.144) in the BI and TAU groups, and to 12 months - 3 (- 5 to - 1) and - 4 (- 7 to - 1), respectively (p = 0.187). In total, 4% (n = 5) of patients in the BI group and 11% (n = 13) of patients in the TAU group were abstinent at 6 months, and 10% (n = 12) and 15% (n = 17), respectively, at 12 months. No between-groups difference in mortality emerged.
CONCLUSION: As underpowered, our study cannot reject or confirm the hypothesis that a single BI early after critical illness is effective in reducing the amount of alcohol consumed compared to TAU. However, a considerable number in both groups reduced their alcohol consumption.
TRIAL REGISTRATION: ClinicalTrials.gov (NCT03047577).
参考来源
- Nissilä E, Hynninen M, Jalkanen V, et al. The effectiveness of a brief intervention for intensive care unit patients with hazardous alcohol use: a randomized controlled trial. Crit Care. 2024. PMID: 38689346. doi:10.1186/s13054-024-04925-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。